M4MM

Week in Review: Cannabis & Psychedelics Industry Highlights

LOS ANGELES – Federal rescheduling under President Trump’s Executive Order sparked widespread state reactions and investor outlooks into early 2026, blending consolidations and expansions with regulatory friction, outright manipulation, and overtures to public opinion. Psychedelics ...

Atai Gains Nasdaq Biotechnology Index Spot

NEW YORK – AtaiBeckley N.V., the clinical-stage biopharmaceutical firm born from the November merger of atai Life Sciences and Beckley Psytech, has secured a place in the Nasdaq Biotechnology Index (NBI), a move that underscores ...

Week in Review: Cannabis & Psychedelics Industry Highlights

LOS ANGELES – Federal rescheduling under President Trump’s Executive Order sparked widespread state reactions and investor outlooks into early 2026, blending consolidations and expansions with regulatory friction, outright manipulation, and overtures to public opinion. Psychedelics ...

Germany Boosts Medical Cannabis Import Cap

BERLIN – German health authorities have increased the annual limit on medical Cannabis imports to 192.5 metric tons, in an effort to keep up with the rapid growth in patient demand while the country navigates ...

FLUENT Consolidates NY Retail Presence

NEW YORK – FLUENT Corp., a Cannabis operator with roots in Florida and Pennsylvania, has completed the rebranding of two key dispensaries in New York, bringing its retail operations in the state under a single ...

Subscribe To Our Newsletter